Moreno, Ana Caroline Rippi; Ribeiro, Bruna Felicio Milazzotto Maldonado Porchia; Pagni, Roberta Liberato; Sousa, Patricia da Cruz; Pegoraro, Rafael; Rodrigues, Karine Bittencourt; Barros, Tácita Borges; Aps, Luana R. de Melo Moraes; Araujo, Eliseu Frank de; Calich, Vera Lucia Garcia; Ferreira, Luís Carlos de Souza 
Source: Frontiers in Immunology. Unidades: ICB, BIOTECNOLOGIA, FCF
Subjects: MELATONINA, IMUNOLOGIA CELULAR, VACINAS VIRAIS, IMUNOTERAPIA, HPV, NEOPLASIAS CUTÂNEAS, HPV, ADJUVANTES IMUNOLÓGICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORENO, Ana Caroline Rippi et al. The combined use of melatonin and an indoleamine 2,3-dioxygenase-1 inhibitor enhances vaccine-induced protective cellular immunity to HPV16-associated tumors. Frontiers in Immunology, v. 9, p. 14 , 2018Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2018.01914. Acesso em: 03 out. 2024.APA
Moreno, A. C. R., Ribeiro, B. F. M. M. P., Pagni, R. L., Sousa, P. da C., Pegoraro, R., Rodrigues, K. B., et al. (2018). The combined use of melatonin and an indoleamine 2,3-dioxygenase-1 inhibitor enhances vaccine-induced protective cellular immunity to HPV16-associated tumors. Frontiers in Immunology, 9, 14 . doi:10.3389/fimmu.2018.01914NLM
Moreno ACR, Ribeiro BFMMP, Pagni RL, Sousa P da C, Pegoraro R, Rodrigues KB, Barros TB, Aps LR de MM, Araujo EF de, Calich VLG, Ferreira LC de S. The combined use of melatonin and an indoleamine 2,3-dioxygenase-1 inhibitor enhances vaccine-induced protective cellular immunity to HPV16-associated tumors [Internet]. Frontiers in Immunology. 2018 ; 9 14 .[citado 2024 out. 03 ] Available from: https://doi.org/10.3389/fimmu.2018.01914Vancouver
Moreno ACR, Ribeiro BFMMP, Pagni RL, Sousa P da C, Pegoraro R, Rodrigues KB, Barros TB, Aps LR de MM, Araujo EF de, Calich VLG, Ferreira LC de S. The combined use of melatonin and an indoleamine 2,3-dioxygenase-1 inhibitor enhances vaccine-induced protective cellular immunity to HPV16-associated tumors [Internet]. Frontiers in Immunology. 2018 ; 9 14 .[citado 2024 out. 03 ] Available from: https://doi.org/10.3389/fimmu.2018.01914
